财中社1月10日电药明康德(603259/02359)发布公告,宣布根据2022年H股奖励信托计划,进一步授予10万股奖励股份给17名选定参与者,这些股份占截至公告日期公司已发行H股总数的约0.027%及已发行总股本的约0.0036%。此次授予的股份由受托人通过场内交易以现行市价收购,且不涉及新股份的发行,因此不会对现有股东的股权造成稀释影响。
此外,公告还提到,由于服务供应商卓佳的办事处迁址,公司香港主要营业地点的地址已于2025年1月10日起变更。新地址为香港铜锣湾希慎道33号利园一期19楼1910室。此次变更是因服务供应商的运营需要,未涉及关联交易的情况。
2024年前三季度,药明康德实现收入277.02亿元,归母净利润65.33亿元。
(文章来源:财中社)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.